Aug 13, 2020
INVO Bioscience Reports Second Quarter 2020 Financial Results
Jun 19, 2020
A Vista Partners Interview with Steve Shum CEO of INVO Bioscience Regarding Increasing Access to Care for Fertility Treatment
May 22, 2020
INVO Bioscience Announces 1-for-20 Reverse Stock Split
May 15, 2020
INVO Bioscience Reports First Quarter 2020 Financial Results
Apr 02, 2020
INVO Bioscience Appoints Christopher Myer as VP Business Development - Americas
Mar 30, 2020
INVO Bioscience Reports 2019 Financial Results
Mar 16, 2020
INVO Bioscience Changes Trading Symbol to "INVO" Effective March 16, 2020
Feb 13, 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Feb 05, 2020
INVO Bioscience Receives IRB Approval to Begin Clinical Study Aimed at Expanded INVOcell Labeling
Nov 14, 2019
INVO Bioscience Reports Third Quarter 2019 Financial Results
Nov 12, 2019
INVO Bioscience Expands its Presence in Eurasia with New Distribution Agreements to Commercialize the INVOcell In Vivo Fertilization System
Oct 31, 2019
INVO Bioscience New CEO Sends Open Letter to Shareholders
Oct 01, 2019
INVO Bioscience to Exhibit at Two Upcoming Scientific and Research Conferences
Aug 14, 2019
INVO Bioscience Reports Record Second Quarter 2019 Financial Results with Revenue Increasing 498%
Jun 13, 2019
INVO Bioscience's INVOcell Technology Featured in IVF Exhibit at the Science Museum in London
Apr 16, 2019
INVO Bioscience Reports Record Fourth Quarter and Year End 2018 Financial Results
Jan 14, 2019
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell(TM) System for Use in the Treatment of Infertility
Nov 29, 2018
INVO Bioscience to Present at the LD Micro Conference
Nov 13, 2018
INVO Bioscience Enters Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell(TM) System for Use in the Treatment of Infertility
Oct 30, 2018
Alabama Fertility Welcomes the First INVOcell Baby In the State of Alabama